Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Anhedonia and its correlation with clinical aspects in Parkinson’s disease
Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Anti-GAD antibody cerebellar ataxia mimicking multiple system atrophy
Ataxia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease
- 12:00pm-1:30pm
-
Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder
Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Apraxia in Parkinson’s disease
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Are limbic and cognitive effects on balance in Parkinson’s disease equal?
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Assessment of brainstem function with blink reflex variations in Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 54
- Next Page»